These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32522847)

  • 1. COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions.
    Kulkarni P; Mahadevappa M
    Postgrad Med J; 2020 Jul; 96(1137):436-437. PubMed ID: 32522847
    [No Abstract]   [Full Text] [Related]  

  • 2. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
    Roffi M; Guagliumi G; Ibanez B
    Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
    Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
    Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
    [No Abstract]   [Full Text] [Related]  

  • 4. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
    Li YH; Huang WC; Hwang JJ;
    Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy.
    Folino AF; Zorzi A; Cernetti C; Marchese D; Pasquetto G; Roncon L; Saccà S; Themistoclakis S; Turiano G; Verlato R; Perazzolo Marra M; Gregori D; Iliceto S
    Am Heart J; 2020 Aug; 226():26-28. PubMed ID: 32497912
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.
    De Filippo O; D'Ascenzo F; Angelini F; Bocchino PP; Conrotto F; Saglietto A; Secco GG; Campo G; Gallone G; Verardi R; Gaido L; Iannaccone M; Galvani M; Ugo F; Barbero U; Infantino V; Olivotti L; Mennuni M; Gili S; Infusino F; Vercellino M; Zucchetti O; Casella G; Giammaria M; Boccuzzi G; Tolomeo P; Doronzo B; Senatore G; Grosso Marra W; Rognoni A; Trabattoni D; Franchin L; Borin A; Bruno F; Galluzzo A; Gambino A; Nicolino A; Truffa Giachet A; Sardella G; Fedele F; Monticone S; Montefusco A; Omedè P; Pennone M; Patti G; Mancone M; De Ferrari GM
    N Engl J Med; 2020 Jul; 383(1):88-89. PubMed ID: 32343497
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
    Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
    Lotfi AS; Capatina A; Kugelmass AD
    Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
    [No Abstract]   [Full Text] [Related]  

  • 9. Who Has Seen Patients With ST-Segment-Elevation Myocardial Infarction? First Results From Italian Real-World Coronavirus Disease 2019.
    Cammalleri V; Muscoli S; Benedetto D; Stifano G; Macrini M; Di Landro A; Di Luozzo M; Marchei M; Mariano EG; Cota L; Sergi D; Bezzeccheri A; Bonanni M; Baluci M; De Vico P; Romeo F
    J Am Heart Assoc; 2020 Oct; 9(19):e017126. PubMed ID: 32901560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
    Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
    Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
    Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak.
    Ferlini M; Andreassi A; Carugo S; Cuccia C; Bianchini B; Castiglioni B; D' Urbano M; Guagliumi G; Lettieri C; Lettino M; Marenzi G; Metra M; Migliori M; Montorfano M; Oliva F; Savonitto S; Seregni R; Visconti LO
    Int J Cardiol; 2020 Aug; 312():24-26. PubMed ID: 32339543
    [No Abstract]   [Full Text] [Related]  

  • 13. Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle.
    Félix-Oliveira A; de Sousa Almeida M; Ferreira J; Campante Teles R; Mesquita Gabriel H; Cavaco D; Mendes M
    Rev Port Cardiol (Engl Ed); 2020 May; 39(5):299-301. PubMed ID: 32423627
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
    Mafham MM; Spata E; Goldacre R; Gair D; Curnow P; Bray M; Hollings S; Roebuck C; Gale CP; Mamas MA; Deanfield JE; de Belder MA; Luescher TF; Denwood T; Landray MJ; Emberson JR; Collins R; Morris EJA; Casadei B; Baigent C
    Lancet; 2020 Aug; 396(10248):381-389. PubMed ID: 32679111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
    Kirtane AJ; Bangalore S
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
    [No Abstract]   [Full Text] [Related]  

  • 16. Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?
    Rangé G; Hakim R; Motreff P
    Eur Heart J Qual Care Clin Outcomes; 2020 Jul; 6(3):223-224. PubMed ID: 32348457
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
    Sudhakar D; Jneid H; Lakkis N; Kayani WT
    Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.
    Elbadawi A; Mahtta D; Elgendy IY; Saad M; Krittanawong C; Hira RS; Omer M; Ogunbayo GO; Garratt K; Rao SV; Jneid H
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2312-2314. PubMed ID: 33032721
    [No Abstract]   [Full Text] [Related]  

  • 19. Declines in Acute Cardiovascular Emergencies During the COVID-19 Pandemic.
    Zaleski AL; Taylor BA; McKay RG; Thompson PD
    Am J Cardiol; 2020 Aug; 129():124-125. PubMed ID: 32593434
    [No Abstract]   [Full Text] [Related]  

  • 20. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
    Bainey KR; Bates ER; Armstrong PW
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.